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DObjective: The aim of the present study was to assess the efficacy and mid- to long-term results of different
cerebral protection techniques in the treatment of acute type A aortic dissection.
Methods: Between April 1987 and January 2011, 329 patients (220 male patients; median age, 60 years; range,
16-87) with type A aortic dissection underwent replacement of the ascending aorta or aortic arch with an open
distal anastomosis. Either hypothermic circulatory arrest alone at 18C (n ¼ 116; 35%) or combined with ret-
rograde cerebral perfusion (n ¼ 122; 37%) or antegrade cerebral perfusion at 25C (n ¼ 91; 28%) was used.
Results: The median circulatory arrest time was 30 minutes (range, 12-92). The overall 30-day mortality was
19% (62 of 329). The 30-day mortality stratified by group was 26% (30 patients) in the hypothermic circulatory
arrest group, 16% in the retrograde cerebral perfusion group (20 patients), and 13% (12 patients) in the ante-
grade cerebral perfusion group (P ¼ .047). Permanent neurologic dysfunction occurred in 53 patients (16%),
with statistically significant differences among the 3 groups (23% for hypothermic circulatory arrest, 12%
for retrograde cerebral perfusion, and 12% for antegrade cerebral perfusion; P ¼ .033). Univariate analysis
showed a significant effect of the brain protection strategy on 30-day mortality and neurologic outcome. Mul-
tivariate analysis revealed preoperative hemodynamic instability, preoperative resuscitation, age, and operative
year as independent predictors of 30-day mortality. Regarding permanent neurologic dysfunction, the multivar-
iate analysis could not identify any independent predictors. Kaplan-Meier analyses revealed statistically signif-
icant differences among the 3 groups with a 1-, 3-, and 5-year survival rate of 84%, 79%, and 77% with
antegrade cerebral perfusion, 75%, 72%, and 66% with retrograde cerebral perfusion, and 66%, 62%, and
60% with hypothermic circulatory arrest alone.
Conclusions: Patients in the antegrade cerebral perfusion group had the best short- and long-term survival rates.
However, during the study period, several significant improvements in the treatment of patients with type A aor-
tic dissection were achieved; therefore, independent predictors of mortality and permanent neurologic dysfunc-
tion were difficult to identify. (J Thorac Cardiovasc Surg 2013;146:647-55)Supplemental material is available online.
Acute aortic dissection type A is a devastating event associ-
ated with major morbidity and mortality requiring immedi-
ate surgical repair. The goal of surgical intervention is
operative survival. To achieve this, the only causative option
for patients with acute aortic dissection is replacement of
the dissected ascending aorta to prevent myocardialhe Department of Cardiac Surgery, Vienna Medical University, Vienna,
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The Journal of Thoracic and Caischemia and cardiac tamponade. The International Regis-
try of Acute Aortic Dissection data reported an in-hospital
mortality rate of 26% in the current era.1 Cerebral protec-
tion during surgery is crucial for postoperative survival
and positive neurologic outcomes.2-4 During the past
decades, various cerebral protection methods have been
used. They have all been based on hypothermic
circulatory arrest (HCA), which was introduced clinically
by Griepp and colleagues5 in 1975. In addition to HCA
alone, cerebral perfusion strategies have been developed
to prolong the safe duration of circulatory arrest. In 1986,
selective antegrade perfusion of the brain with cold blood
during surgery of the aortic arch was introduced by Bachet
and colleagues.6 Retrograde cerebral perfusion (RCP) was
first used in dissection patients by Ueda and colleagues.7
These techniques have been described in numerous pub-
lished studies and have been widely used; however, data
from large clinical trials are scarce.8
The present study was undertaken to compare the experi-
ence and results in patients undergoing surgery for acute
type A dissection with 3 different cerebral protection
methods at a single center. Particular emphasis was placedrdiovascular Surgery c Volume 146, Number 3 647
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
bACP ¼ bilateral ACP
CPB ¼ cardiopulmonary bypass
HCA ¼ hypothermic circulatory arrest
PND ¼ permanent neurologic deficit
RCP ¼ retrograde cerebral perfusion
uACP ¼ unilateral ACP
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Donmortality, both in-hospital and long-term, and neurologic
outcome.
PATIENTS AND METHODS
The data from 329 patients with acute aortic dissection type A undergo-
ing replacement of the ascending aorta or aortic arch with an open distal
anastomosis at a single center (Department of Cardiac Surgery, Vienna
Medical University) between April 1987 and January 2011 were prospec-
tively collected and retrospectively analyzed. The demographic data are
listed in Table 1.
Study Groups
The patients were categorized according to the cerebral protection
method used into 1 of 3 groups: HCA alone (n ¼ 116; 35%), HCA
combined with RCP (n ¼ 122; 37%), and HCA combined with ante-
grade cerebral perfusion (ACP; n ¼ 91; 28%; Figure 1). The type of ce-
rebral protection was at the surgeon’s discretion for the whole study
period.
Definitions
All cases of hemiplegia and paraplegia and every other neurologic def-
icit resulting from either central or peripheral neurologic damage that was
still present at discharge from the hospital was defined as a permanent neu-
rologic deficit (PND). Liver failure was defined as a significant increase in
transaminases and an increase in prothrombin time of at least 10%. Near
infrared spectroscopy was introduced as a neuromonitoring tool in 1998.
Since then, it was used in 150 patients.
Operative Technique
All operations were performed by way of a median sternotomy.
After patients had received heparin (330 IU/kg body weight), cardio-
pulmonary bypass (CPB) was established through either the femoral
artery or right subclavian artery and the right atrium. In cases of tam-
ponade, the strategy was chosen according to patient stability. In hemo-
dynamically stable patients with beginning tamponade, CPB was
established before sternotomy. In the case of hemodynamic instability
and cardiac tamponade, sternotomy was performed before cannulation,
and the heart was decompressed by a small incision into the
pericardium.
Once CPB had been established, systemic cooling was immediately ini-
tiated. A left ventricular vent was placed through the right superior pulmo-
nary vein, and a retrograde cardioplegia catheter was placed into the
coronary sinus. For central neurologic protection, the patient’s head was
packed in ice bags, and 1000 mg of methylprednisolone was given before
the onset of HCA. The ascending aorta was replaced with an open distal
anastomosis, if the entry tear or acute type A dissection was located in
the aortic root or aortic arch. Surgical therapy also included repair or re-
placement of the involved structures, such as the aortic valve, aortic root,
and/or aortic arch. For HCA and RCP, CPB was stopped after the patient648 The Journal of Thoracic and Cardiovascular Surgwas cooled to the target esophageal temperature of 18C. In the
case of ACP, circulatory arrest was initiated at an esophageal temperature
of 25C.
Two different strategies were used to establish ACP. In the case of sub-
clavian artery cannulation for CPB, we snared all supra-aortic arch vessels,
including the brachiocephalic trunk, after securing adequate backflow. In
the case of femoral artery cannulation for CPB, we inserted a cannula under
direct vision into the brachiocephalic trunk, and snared the vessel after-
ward. In the case of bilateral ACP, the left carotid artery was selectively in-
tubated and perfused after opening the arch. The brain was perfused with
blood at a temperature of 25C, with a flow rate of 10 mL/kg/min body
weight. The lower body was kept in circulatory arrest. In the case of
RCP, a 28F cannula was advanced into the superior vena cava, snared cra-
nially of the azygos vein, and connected to the arterial line. Retrograde flow
was slowly increased and regulated to achieve a target central venous pres-
sure of 20 mm Hg. Maintenance of adequate retrograde flow volume re-
quired infusion of 500 to 1000 mL. This resulted in a median flow rate
of 280 mL/min (range, 50-650).
Statistical Analysis
The data from the patients were analyzed using SPSS statistical soft-
ware (PASW, version 18.0, for Macintosh; IBM Corp, Somers, NY). Cat-
egorical variables are presented as numbers and percentages and
continuous variables as medians and ranges. For comparison of continuous
variable, we used 1-way analysis of variance testing when 3 groups were
compared and the Mann-Whitney U test when 2 groups were compared.
Categorical variables were compared using the c2 test. Survival was com-
pared using Kaplan-Meier analysis and log-rank testing. The most impor-
tant factors influencing 30-day mortality and PND rates were entered in
a binary regression model.RESULTS
Demographic Data
The 3 groups did not differ significantly with respect to
gender, preoperative neurologic deficit (including transient
ischemic attack, prolonged reversible ischemic neurologic
deficit, and stroke), coronary artery disease, myocardial in-
farction, previous cardiac surgery, cardiopulmonary resus-
citation, and renal failure.
Rupture, hemodynamic instability, arterial hypertension,
and pulmonary dysfunction were found more frequently in
the HCA only and RCP groups. The RCP patients were
significantly younger at surgery (Table 1).Mortality and Neurologic Outcome
The overall 30-day mortality was 19% (62 of 329), with
statistically significant differences among the different ce-
rebral protection methods during circulatory arrest. The
mortality was 26% in the HCA group (30/116), 16% in
the HCA plus RCP group (20/122), and 13% (12/91) in
the HCA plus ACP group (P ¼ .047).
The predominant cause of death within 30 days was car-
diac failure (n ¼ 24) followed by multiorgan failure
(n ¼ 14), bleeding episodes (n ¼ 9), neurologic complica-
tions (n ¼ 7), sepsis (n ¼ 5), and pulmonary failure
(n ¼ 2). In 1 patient, the cause of death was unknown
(see Table E1).ery c September 2013
TABLE 1. Demographic data
Variable Overall HCA only RCP ACP P value
Patients (n) 329 116 122 91
Age at surgery (y) 60 (16-87) 60 (16-84) 56(18-87) 62 (33-85) .043
Male gender 220 (67%) 82 (71%) 75 (62%) 63 (69%) .273
Preoperative PRIND 2 (1%) 1 (1%) 0 1 (1%) .530
Preoperative TIA 11 (3%) 4 (3%) 6 (5%) 1 (1%) .320
Preoperative stroke 7 (2%) 3 (3%) 3 (3%) 1 (1%) .730
Hemodynamic instability 60 (18%) 28 (24%) 25 (21%) 7 (8%) .014
Rupture 147 (45%) 55 (47%) 69 (57%) 23 (25%) <.001
Cardiopulmonary resuscitation 12 (4%) 5 (4%) 6 (5%) 1 (1%) .674
Pulmonary dysfunction 70 (21%) 29 (25%) 33 (27%) 8 (9%) .003
Myocardial infarction 18 (6%) 4 (3%) 9 (7%) 5 (6%) .413
Coronary artery disease 49 (15%) 19 (16%) 20 (16%) 10 (11%) .481
Arterial hypertension 279 (85%) 104 (90%) 107 (88%) 68 (74%) .011
Renal failure 23 (7%) 6 (5%) 10 (8%) 7 (8%) .618
Previous cardiac surgery 19 (6%) 7 (6%) 7 (6%) 5 (6%) .986
Data presented as median (range) or number (%). HCA, Hypothermic circulatory arrest; RCP, retrograde cerebral perfusion; ACP, antegrade cerebral perfusion; PRIND,
prolonged reversible ischemic neurologic deficit; TIA, transient ischemic attack.
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DOf the 329 patients, 53 (16%) developed PND: 27 (23%)
in the HCA-only group, 15 (12%) in the RCP group, and 11
(12%) in the ACP (P ¼ .033; Tables 2 and 3).
Long-term survival analyses also revealed significant dif-
ferences among the 3 groups. The survival at 1, 3, 5, and 10
years was 66%, 62%, 60%, and 50% in the HCA-only
group and 75%, 72%, 66%, and 51% in the RCP group,
respectively; the 1-, 3-, and 5-year survival in the ACP
group was 84%, 79%, and 77%, respectively (median
follow-up, 63 months; range, 1-290; P ¼ .035; Figure 2).FIGURE 1. Percentage of use for 3 different cerebral protection strate-
gies: hypothermic circulatory arrest (HCA) only (n ¼ 116), retrograde ce-
rebral perfusion (RCP) (n ¼ 122), and antegrade cerebral perfusion (ACP)
(n ¼ 91).
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In 53 (58%) of the 91 ACP patients, cerebral perfusion
was performed unilaterally (uACP) and in 38 (42%), bilat-
erally (bACP; Figure 3). A subgroup analysis between
those 2 groups was performed. The 30-day mortality for
the uACP patients was 19% (10 of 53) and was 5%
(2 of 38) for the bACP patients (P ¼ .059). The circulatory
arrest time was slightly longer for the bACP group
(29 minutes, range, 11-74; vs 33 minutes, range, 15-113;
P ¼ .023). The PND rates were comparable in both groups
(uACP, 7 [14%]; and bACP, 4 [11%]; P ¼ .699). The
incidence of postoperative renal failure rate (requiring di-
alysis) was greater in the bACP group than in the uACP
group (12 [32%] vs 5 [9%], respectively; P ¼ .0173;
Table 4).
Kaplan-Meier analysis revealed no significant differ-
ences in long-term survival between the bACP and uACP
groups (1-, 3-, and 5-year survival rate, 90%, 81%, and
73% vs 79%, 77%, and 77%, respectively; P ¼ .885).
The median follow-up was 43 months (range, 1-108;
Figure 4).Risk Factors for Perioperative Mortality
A comparison of the data from the patients who survived
30 days postoperatively and those who died revealed that
the nonsurvivors were significantly older (median age, 65
years; range, 32-84; vs 59 years; range, 16-87;
P ¼ .023), were more frequently hemodynamically unsta-
ble preoperatively (44% vs 12%, P<.001), required resus-
citation more often (16% vs 1%, P < .001), and had
a significantly greater rate of aortic rupture (58% vs
42%, P ¼ .019). The CPB time, aortic crossclamp time,
and length of circulatory arrest were slightly longer among
the nonsurvivors. Finally, HCA only was used more fre-
quently in nonsurvivors (32% vs 48%; P ¼ .016), withrdiovascular Surgery c Volume 146, Number 3 649
TABLE 2. Intraoperative data
Variable Overall HCA only RCP ACP P value
Patients (n) 329 116 122 91
CPB time (min) 180 (101-404) 177 (101-355) 198 (121-404) 161 (101-303) <.01
Crossclamp time (min) 109 (61-230) 107 (61-203) 114 (62-230) 109 (61-179) <.037
Circulatory arrest time (min) 30 (12-92) 36 (12-88) 30 (14-88) 30 (14-92) .993
Cooling time (min) 56 (18-162) 51 (26-132) 63 (30-162) 47 (18-150) <.01
Aortic valve surgery 98 (30%) 44 (38%) 33 (27%) 21 (23%) .052
David operation 6 (2%) 2 (2%) 2 (2%) 2 (2%) .951
Complete arch 7 (2%) 0 3 (3%) 4 (4%) .089
Composite graft 57 (17%) 25 (22%) 19 (16%) 12 (14%) .317
‘‘Elephant trunk’’ 2 (1%) 1 (1%) 1 (1%) 0 .680
Stent graft 22 (7%) 7 (6%) 6 (5%) 9 (10%) .335
Mitral valve surgery 3 (1%) 1 (1%) 1 (1%) 1 (1%) .975
CABG 27 (8%) 11 (10%) 10 (8%) 6 (6%) .754
Reoperation 94 (29%) 29 (25%) 44 (36%) 21 (23%) .083
Data presented as median (range) or number (%). HCA, Hypothermic circulatory arrest; RCP, retrograde cerebral perfusion; ACP, antegrade cerebral perfusion; CPB, cardio-
pulmonary bypass; CABG, coronary artery bypass grafting.
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(P ¼ .069; Table 5).
Multivariate analyses revealed preoperative hemody-
namic instability, cardiopulmonary resuscitation, patient
age at surgery, and operative year as independent predictors
of 30-day mortality (Table 6). The operative year reached
significance (P ¼ .048) but only with a regression coeffi-
cient of0.074 and an odds ratio of 0.929.Risk Factors for PND
No significant demographic differences were found
among patients with a PND. In patients with PND, HCA
only had been used more frequently (51% vs 32%,
P ¼ .008). Also, more patients with a PND required surgi-
cal revision (45% vs 25%. P ¼ .006; Table 7). In the mul-
tivariate regression model, adding the operative year as
a continuous variable removed every significant influence
of any factor; thus, not HCA nor previous cardiac surgeryTABLE 3. Postoperative data
Variable Overall HCA o
Patients (n) 329 116
30-d Mortality 62 (19%) 30 (26%
Ventilation time (d) 3 (1-79) 3 (1-5
ICU stay (h) 6 (1-86) 5 (1-7
PND 53 (16%) 27 (23%
TIA 3 (1%) 1 (1%
Liver failure 8 (2%) 5 (4%
Renal failure (requiring dialysis) 53 (16%) 20 (17%
Multiorgan failure 25 (8%) 11 (10%
Reintubation 23 (7%) 9 (8%
Sepsis 39 (12%) 23 (20%
Hospital stay (d) 19 (3-96) 19 (5-7
Data presented as number (%) or median (range). HCA, Hypothermic circulatory arrest; R
care unit; PND, permanent neurologic deficit; TIA, transient ischemic attack.
650 The Journal of Thoracic and Cardiovascular Surgnor operative year was an independent factor in our analysis
(Table 8).Developments in Type A Aortic Dissection Treatment
The study period was 24 years from April 1987 to Jan-
uary 2011, and, in addition to ACP and RCP, a number of
other significant improvements were achieved, including
earlier and better diagnosis, a quicker referral to surgery,
and better anesthetic management. We stratified the pa-
tients according to the era of surgery for type A aortic dis-
section into 3 groups: 1987 to 1996 (period 1), 1997 to
2004 (period 2), and 2005 to 2011 (period 3). These
periods were selected according to the introduction of
new techniques, with a certain overlap. A comparison of
the pre- and intraoperative patient characteristics
showed that the rates of preoperative hemodynamic insta-
bility (22% vs 21% vs 9%, P ¼ .052) and aortic rupture
(43% vs 58% vs 22%, P<.001) decreased significantlynly RCP ACP P value
122 91
) 20 (16%) 12 (13%) .047
4) 4 (1-79) 2 (1-45) .168
3) 7 (1-86) 5 (1-62) .041
) 15 (12%) 11 (12%) .033
) 0 2 (2%) .253
) 3 (3%) 0 .130
) 16 (13%) 17 (19%) .454
) 13 (11%) 1 (1%) .023
) 12 (10%) 2 (2%) .866
) 12 (10%) 4 (4%) .002
7) 20 (5-96) 17 (3-88) .522
CP, retrograde cerebral perfusion; ACP, antegrade cerebral perfusion; ICU, intensive
ery c September 2013
FIGURE 2. Kaplan-Meier survival analysis curves for antegrade cerebral
perfusion (ACP) versus retrograde cerebral perfusion (RCP) versus hypo-
thermic circulatory arrest (HCA) only (log rank, P ¼ .035; median
follow-up, 63 months; range, 1-290).
FIGURE 3. Percentage of patients in antegrade cerebral perfusion (ACP)
group perfused either unilaterally (uACP) or bilaterally (bACP).
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(Table 9). Although this difference was statistically signif-
icant in the case of aortic rupture, it did not reach signif-
icance for hemodynamic instability. The rate of
preoperative cardiopulmonary resuscitation remained the
same for all 3 periods. A comparison of the cerebral pro-
tection strategies revealed HCA only as the main strategy
for period 1 (74%), with 26% receiving RCP. During
period 2, RCP was the dominant strategy (56%), with
HCA only decreasing to 27% and ACP, which was not
known in period 1, emerging as a new treatment modality
(16%). In period 3, ACP had become the method of
choice (76%), with HCA only (11%) and RCP (13%)
used only occasionally (P< .001).
Both mortality and the incidence of PND decreased
significantly during the study period. The 30-day mortal-
ity was 31% in period 1, 16% in period 2, and 11% in
period 3 (P ¼ .001). The corresponding PND rates
were 27%, 13%, and 11% (P ¼ .007). Kaplan-Meier
analysis revealed a 1-, 3-, 5-, and 10-year survival rate
of 56%, 51%, 49%, and 34% in period 1 compared
with 77%, 73%, 70%, and 59% in period 2, respec-
tively. By contrast, the 1-, 3-, and 5-year survivalThe Journal of Thoracic and Carate in period 3 was 87%, 85%, and 82%, respectively
(P< .001; Figure 5).
DISCUSSION
Taken together, our data indicate that the outcome of
surgical treatment of type A dissection at our center has
improved over time and that ACP at hypothermic circula-
tory arrest yields the best results with regard to mortality
and PND.
Acute dissection of the aorta was first described in detail
in 1760 when King George II died of this condition.9 It is
a catastrophic event that represents a formidable surgical
challenge. Without surgery, 50% of patients die within
the first 48 hours, and the 2-week mortality rate approaches
80% in patients with undiagnosed or untreated ascending
aortic dissection.1,10,11 With improved preoperative
diagnosis, better prosthetic material, amelioration of
cardiac and cerebral protection, and increased surgical
experience, the results have improved during the past 20
years.12,13 However, the average mortality in most
registries remains 20% to 25%.2,14,15
Surgical treatment of type A aortic dissection consists
primarily of replacement of the ascending aorta to exclude
the entry tear and prevent expansion of the dissection to-
ward the aortic root and rupture into the pericardial sac.
In about 10% of patients, the aortic root is involved, and
5% of the patients require replacement of the entire aortic
arch. Deep HCA is the most commonly used method of ce-
rebral protection during surgery of the aortic arch. However,
this technique offers only a limited period for arch repair.
Also, it requires prolonged CPB to rewarm the patient,rdiovascular Surgery c Volume 146, Number 3 651
TABLE 4. Subgroup analysis of unilateral ACP vs bilateral ACP
Variable uACP bACP P value
Patients (n) 53 (58%) 38 (42%)
CPB time (min) 165 (101-303) 157 (102-285) .243
Aortic crossclamp time (min) 109 (62-166) 95 (61-179) .717
Circulatory arrest time (min) 32 (15-88) 29 (12-74) .152
Cooling time (min) 47 (21-120) 45 (18-150) .218
Aortic valve surgery 12 (23%) 9 (24%) .946
David operation 2 (4%) 0 .226
Complete arch 1 (2%) 3 (8%) .168
Composite graft 10 (19%) 3 (8%) .140
‘‘Elephant trunk’’ 0 0
Stent graft 7 (13%) 2 (5%) .211
Mitral valve surgery 1 (2%) 0 .395
CABG 2 (4%) 4 (11%) .201
Reoperation 12 (23%) 9 (24%) .986
30-d Mortality 10 (19%) 2 (5%) .059
Ventilation time (d) 3 (1-45) 1 (1-14) .308
ICU stay (h) 5 (1-62) 4 (1-55) .308
Hospital stay (d) 16 (3-83) 21 (7-88) .346
Transitory psychotic syndrome 6 (11%) 0 .027
PND 7 (14%) 4 (11%) .699
TIA 1 (2%) 1 (3%) .855
Renal failure
(requiring dialysis)
5 (9%) 12 (32%) .013
Multiorgan failure 1 (2%) 0 .376
Reintubation 1 (2%) 1 (3%) .361
Sepsis 1 (2%) 3 (8%) .196
Data presented as number (%) or median (range). ACP,Antegrade cerebral perfusion;
uACP, unilateral ACP; bACP, bilateral ACP; CPB, cardiopulmonary bypass; CABG,
coronary artery bypass grafting; ICU, intensive care unit; PND, permanent neurologic
deficit; TIA, transient ischemic attack.
FIGURE 4. Kaplan-Meier survival analysis curves for unilateral ante-
grade cerebral perfusion (uACP) versus bilateral ACP (bACP) (log rank,
P ¼ .885; median follow-up, 43 months; range, 1-108).
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such as severe bleeding and an intense requirement for
blood products.5
Although these surgical treatment modalities have not
changed dramatically during the past 35 years, the develop-
ment of better cerebral protection methods has been an im-
portant focus of aortic surgical research. In 1990, Ueda and
colleagues7 reported a series of patients with RCP through
the superior vena cava during arch exclusion. Coselli and
colleagues16 reported that the mortality (7.9%) and stroke
rate (2.4%) of patients undergoing aortic surgery with
RCP were favorable. These favorable results were con-
firmed by other small clinical trials, and the technique of
RCP became widely adopted.17 The technique of ACP
had already been described in 19866; however, it only be-
came standard in most centers during the past 5 to 10 years.6
Although the experience with RCP is now more than 2 de-
cades, controversy still exists about whether RCP has a
neuroprotective effect above and beyond that provided by
HCA. Some uptake of oxygen during retrograde flow
clearly occurs; however, most efforts to document signifi-
cant improvement in cerebral metabolic function owing to
nutritive flow during RCP have failed. Furthermore,652 The Journal of Thoracic and Cardiovascular Surgexperimental studies have shown that significant shunting
of blood away from the brain occurs during RCP by way
of venovenous anastomoses.17,18 The only effect that RCP
might have is a positive influence on cooling, which helps
to protect the brain, especially in patient with insufficient
systemic cooling. Although ACP has became the standard
approach for an ever-increasing number of centers world-
wide,19 no consensus has been reached among cardiac sur-
geons concerning the optimal strategy and temperature
management for cerebral protection during acute aortic dis-
section type A surgery. The broad range of preoperative
conditions, pathologic anatomic features, complications,
and surgical procedures in patients with acute aortic dissec-
tion type A and the diversity of CPB strategies has ham-
pered comparisons of postoperative outcomes and the
available data.8 Most publications on this topic have con-
tained data from registries, which have the advantage of in-
cluding a large number of patients. However, the
disadvantage of such registries is that they include data
from various centers with several different strategies in op-
erative and anaesthesiologic management.ery c September 2013
TABLE 5. Survivors vs nonsurvivors at 30 days
Variable
30-d
Survivors
30-d
Nonsurvivors
P
value
Patients (n) 267 62
Age at surgery (y) 59 (16-87) 65 (32-84) .023
Male gender 181 (68%) 39 (63%) .461
Preoperative PRIND 2 (1%) 0 .494
Preoperative TIA 10 (4%) 1 (2%) .405
Preoperative stroke 7 (3%) 0 .198
Hemodynamic instability 33 (12%) 27 (44%) <.001
Rupture 111 (42%) 36 (58%) .019
CPR 2 (1%) 10 (16%) <.001
Intubated 53 (20%) 17 (27%) .172
Myocardial infarction 16 (6%) 2 (3%) .398
Coronary artery disease 37 (14%) 12 (20%) .173
Arterial hypertension 226 (85%) 53 (87%) .658
Renal failure 19 (7%) 4 (7%) .872
Previous cardiac surgery 12 (5%) 7 (11%) .051
CPB time (min) 179 (101-316) 198 (103-404) .001
Aortic crossclamp time (min) 108 (61-230) 118 (67-199) .021
Circulatory arrest time (min) 29 (15-92) 34 (14-88) .037
Cooling time (min) 55 (18-162) 57 (28-132) .341
Aortic valve surgery 76 (29%) 22 (36%) .284
David operation 6 (2%) 0 .234
Complete arch 5 (2%) 2 (3%) .506
Composite graft 40 (15%) 17 (27%) .020
‘‘Elephant trunk’’ 2 (1%) 0 .648
Stent graft 20 (8%) 2 (3%) .226
CABG 18 (7%) 9 (15%) .045
Reoperation 73 (28%) 20 (32%) .130
HCA only 86 (32%) 30 (48%) .016
RCP 102 (38%) 20 (32%) .383
ACP 79 (30%) 12 (19%) .069
Data presented as median (range) or number (%). PRIND, Prolonged reversible is-
chemic neurologic deficit; TIA, transient ischemic attack; CPR, cardiopulmonary re-
suscitation; CPB, cardiopulmonary bypass; CABG, coronary artery bypass grafting;
HCA, hypothermic circulatory arrest; RCP, retrograde cerebral perfusion; ACP, ante-
grade cerebral perfusion.
TABLE 7. Permanent neurologic deficit vs none
Variable
PND
P valueYes No
Patients (n) 53 (16%) 276 (84%)
Age at surgery (y) 64 (31-87) 59 (16-85) .178
Male gender 37 (70%) 183 (66%) .372
Preoperative PRIND 0 2 (1%) .710
Preoperative TIA 2 (4%) 9 (3%) .535
Preoperative stroke 2 (4%) 5 (2%) .304
Hemodynamic instability 14 (26%) 46 (16%) .156
Rupture 29 (55%) 118 (43%) .073
CPR 4 (8%) 8 (3%) .1
Intubated 15 (28%) 55 (20%) .125
Myocardial infarction 4 (8%) 14 (5%) .316
Coronary artery disease 11 (21%) 38 (14%) .142
Arterial hypertension 47 (89%) 232 (84%) .283
Renal failure 1 (2%) 22 (8%) .091
Previous cardiac surgery 2 (4%) 17 (6%) .378
CPB time (min) 179 (101-304) 180 (101-404) .704
Aortic crossclamp time (min) 107 (62-205) 110 (61-230) .455
Circulatory arrest time (min) 31 (14-72) 30 (12-92) .517
Cooling time (min) 55 (28-143) 56 (18-162) .572
Aortic valve surgery 12 (23%) 86 (31%) .136
David operation 0 6 (2%) .345
Complete arch 3 (6%) 4 (1%) .086
Composite graft 9 (17%) 48 (17%) .562
‘‘Elephant trunk’’ 2 (4%) 0 .026
Stent graft 2 (4%) 20 (7%) .279
Mitral valve surgery 0 3 (1%) .589
CABG 6 (11%) 21 (8%) .255
Reoperation 24 (45%) 70 (25%) .006
HCA only 27 (51%) 89 (32%) .008
RCP 15 (28%) 107 (39%) .097
ACP 11 (21%) 80 (29%) .144
uACP 7 (13%) 45 (16%) .468
bACP 4 (8%) 34 (12%) .468
Liver failure 4 (8%) 4 (1%) .026
Pulmonary failure 10 (19%) 19 (7%) .010
Renal failure
(requiring dialysis)
16 (30%) 37 (13%) .06
Multiorgan failure 5 (9%) 20 (7%) .409
Sepsis 15 (28%) 24 (9%) <.001
Data presented as median (range) or number (%). PND, Permanent neurologic defi-
cit; PRIND, prolonged reversible ischemic neurologic deficit; TIA, transient ischemic
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19%, similar to that in recent reported studies.20,21 In-
hospital mortality was greater among patients in whom
HCA only was used (26%), followed by the RCP group
(16%) and 13% in the ACP group. The same was true forTABLE 6. Multivariate analysis for 30-day mortality
Variable Wald P value OR
Regression
coefficient 95% CI
Age 4.828 .028 1.026 0.026 1.003-1.051
HCA only 1.321 .250 1.539 0.431 0.738-3.213
ACP 0.321 .571 1.354 0.303 0.475-3.862
Hemodynamic
instability
8.970 .003 3.073 1.123 1.474-6.407
CPR 8.732 .003 12.838 2.552 2.362-69.778
Operative year 3.917 .048 0.929 0.074 0.863-0.999
OR, Odds ratio; CI, confidence interval; HCA, hypothermic circulatory arrest; ACP,
antegrade cerebral perfusion; CPR, cardiopulmonary resuscitation.
attack; CPR, cardiopulmonary resuscitation; CPB, cardiopulmonary bypass; CABG,
coronary artery bypass grafting; HCA, hypothermic circulatory arrest; RCP, retro-
grade cerebral perfusion; ACP, antegrade cerebral perfusion; uACP, unilateral ACP;
bACP, bilateral ACP.
The Journal of Thoracic and Calong-term survival. RCP showed major improvement in re-
ducingmortality andPNDbut failed to showbenefit in avoid-
ing temporary neurologic dysfunction. In contrast, ACP, not
only was associated with the lowest hospital mortality and
PND, but also showed a benefit in reducing the occurrence
of transient postoperative neurologic deficits. Similar results
were found by Okita and colleagues22 from Japan.
The significantly lower hospital mortality rate and PND
using ACP compared with RCP or HCA alone in the presentrdiovascular Surgery c Volume 146, Number 3 653
TABLE 8. Multivariate analysis for permanent neurologic deficit
Variable Wald P value
Regression
coefficient OR 95% CI
Age 2.703 .100 0.019 1.019 0.996-1.042
HCA only 2.143 .143 0.519 1.681 0.839-3.370
Previous cardiac
surgery
0.897 .343 0.745 0.475 0.102-2.217
Operative year 3.536 .060 0.058 0.944 0.888-1.002
OR, Odds ratio; CI, confidence interval; HCA, hypothermic circulatory arrest.
FIGURE 5. Survival rates in 3 different eras of aortic surgery (log rank,
P<.001).
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by ACP when prolonged and acute operations on the tho-
racic aorta are undertaken.
In our study, we not only compared the 3 basic methods
of cerebral protection, but also performed a subgroup
analysis of bACP versus uACP. Although, basically the
outcomes in these 2 groups were not significantly different,
there seemed to be at least a trend toward better 30-day
survival in the bACP group. Nevertheless, this result could
have been biased because during the introduction period of
ACP in our center, we did not use near infrared spectros-
copy for continuous neuromonitoring. Therefore, it is pos-
sible that a few of the uACP patients showed a decrease
in oxygen saturation in the near infrared spectroscopy. In
the last years of the study, we have advocated uACP with
continuous neuromonitoring, with the possibility of switch-
ing to bACP in the case of left hemispheric cerebral malper-
fusion, as the procedure of choice for cerebral protection
in patients undergoing surgery for aortic arch pathologic
findings.
Only hemodynamic instability, preoperative cardiopul-
monary resuscitation, patient age, and operative year were
statistically significant independent risk factors forTABLE 9. Study periods for type A aortic dissection surgery
Variable
Period 1
(1987-1996)
Period 2
(1997-2004)
Period 3
(2005-January 2011)
P
value
Patients (n) 86 158 85
Age (y) 57 (16-81) 59 (18-87) 62 (33-85) .183
Male gender 59 (67%) 97 (61%) 64 (75%) .083
Preoperative
hemodynamic
instability
19 (22%) 33 (21%) 8 (9%) .052
CPR 3 (3%) 7 (4%) 2 (2%) .712
Rupture 37 (43%) 91 (58%) 19 (22%) <.001
PND 23 (27%) 21 (13%) 9 (11%) .007
30-d Mortality 27 (31%) 26 (16%) 9 (11%) .001
HCA only 64 (74%) 43 (27%) 9 (11%) <.001
ICU stay 6 (1-86) 6 (1-62) 5 (1-63) .667
RCP 22 (26%) 89 (56%) 11 (13%) <.001
ACP 0 26 (16%) 65 (76%) <.001
Data presented as median (range) or number (%). CPR, Cardiopulmonary resuscita-
tion; PND, permanent neurologic deficit; HCA, hypothermic circulatory arrest; ICU,
intensive care unit; RCP, retrograde cerebral perfusion; ACP, antegrade cerebral per-
fusion.
654 The Journal of Thoracic and Cardiovascular Surgmortality in our patient population. This was not surprising,
and results reported by others would lead to the expectation
that patients with frank rupture and hemodynamic compro-
mise would have a worse outcome than patients who were
stable preoperatively. Also not surprisingly, older patients
with such aortic pathologic findings had worse outcomes
than younger patients.
That concomitant procedures failed to have any effect on
mortality was also reassuring, suggesting that the current
approach at our institution, which involves resecting the
site of the intimal tear and performing adjunctive proce-
dures when clinically indicated, is a reasonable method to
treat acute dissection in a setting in which aneurysm surgery
is a routine procedure. The use of the Bentall-de Bono pro-
cedure depended on the degree of aortic valve insuffciency
and the judgment of the surgeon of whether a competent
valve could be achieved by resuspension. However, various
approaches to the aortic valve—leaving it untouched, re-
placing it, or resuspending the valve leaflets—also had no
effect on mortality. It is possible, however, that some as-
pects of these results might not easily be extrapolated to
institutions with less experience with dissection and aneu-
rysms. It must be emphasized that the principal object of
emergency surgery for acute dissection must be the
immediate survival of the patient, and more limitedery c September 2013
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circumstances.
Study Limitations
The major limitation of the present study was that all data
were analyzed retrospectively, a process that mandates cau-
tion in the interpretation of the results. Factors such as the
‘‘learning curve’’ of each surgeon during the study period
and improvement in intra- and postoperative care cannot
be considered in a retrospective study. Particularly because
of the long observation period, it was very difficult to iden-
tify strong independent predictors of mortality or PND. This
limitation was strongly supported by the finding that includ-
ing the operative year in the multivariate analysis removed
every other independent predictor for PND, leaving only
age, cardiopulmonary resuscitation, and hemodynamic
instability as predictors of mortality. During the past de-
cades, not only have the surgical technique and neuropro-
tective methods improved, but also better anesthesetic
management, earlier and better diagnosis of the disease, ac-
celerated transfer to the operating room, and a higher
awareness of the transferring physicians of the disease are
factors that have led to significant improvements in the out-
comes of patients undergoing surgery for type A aortic
dissection.
CONCLUSIONS
Patients in the ACP group had the best short- and long-
term survival in our series. However, owing to the rather
long study period, several improvements in the treatment
of patients with type A aortic dissection have been
achieved. Therefore, it was difficult to identify ACP as fa-
vorable predictor. Patients in the HCA-only group had sig-
nificantly greater rates of PND. However, on multivariate
regression analysis, HCA could not be identified as an in-
dependent predictor of PND. Finally, 30-day mortality was
mainly influenced by the preoperative hemodynamic sta-
tus, with hemodynamic instability resulting in greater
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TABLE E1. Cause of death (30-day mortality)
Cause of death Patients (n ¼ 62)
Cardiac failure 24
Multiorgan failure 14
Bleeding 9
Neurologic complications 7
Sepsis 5
Pulmonary failure 2
Unknown 1
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